HEICO Corporation

source: coverage-next-full ticker: HEI step: "01" title: Business Overview — What HEICO Does created: 2026-05-29

HEI — Business Overview

Company Summary

HEICO Corporation is the world's largest independent manufacturer of FAA-approved aircraft replacement parts and one of the leading providers of defense electronics. Founded in 1957, HEICO is headquartered in Hollywood, Florida, and has been controlled by the Mendelson family since Larry Mendelson took over in 1990. The company operates as a highly acquisitive conglomerate within aerospace and defense, but with a distinctive culture of financial discipline and decentralized management.

HEICO's core business model is straightforward: it reverse-engineers OEM (Original Equipment Manufacturer) aircraft parts, obtains FAA Parts Manufacturer Approval (PMA), and sells those certified replacement parts to airlines, MROs (Maintenance, Repair & Overhaul shops), and militaries at discounts of 30–40% versus OEM pricing. This value proposition is irresistible to cost-conscious airline operators, and creates enormous switching costs and regulatory moat for HEICO.

Business Segments

Flight Support Group (FSG) — ~65% of Revenue

The FSG is HEICO's original and largest business. It encompasses:

PMA Parts Manufacturing: HEICO engineers PMA-certified replacement parts for aircraft engines (turbine blades, combustion chambers, seals), airframes (structural components, panels), and avionics. As of FY2024, HEICO holds approximately 10,000+ FAA PMA approvals — the broadest catalog in the independent parts industry.

Aviation Parts Distribution: HEICO distributes not only its own PMA parts but also OEM parts, spare parts, and consumables through its distribution network. This allows it to serve as a one-stop shop for MROs and airline maintenance departments.

Repair & Overhaul Services: Through subsidiary companies, FSG also provides component repair, overhaul, and modification services for aviation components.

Key FSG Subsidiaries (illustrative):

• HEICO Aerospace Holdings (PMA manufacturing)
• Seal Dynamics (pneumatic seals, components)
• Air Radio & Instruments (avionics)
• Multiple smaller niche aerospace subsidiaries acquired over 30+ years

Electronic Technologies Group (ETG) — ~35% of Revenue

The ETG makes defense electronics, medical electronics, and industrial electronics. Unlike FSG which operates in commercial aviation aftermarket, ETG primarily serves:

• Defense/Military: Electronic systems, subsystems, components for radar, missile guidance, electronic warfare, communications — typically prime or sub-prime contracts with DoD and allied militaries
• Medical: Specialty electronic components for imaging, diagnostics, radiation therapy
• Industrial/Other: Specialized electronics for non-aviation industrial applications

ETG businesses tend to be highly specialized, niche producers with proprietary designs, often with long product cycles and sole-source positions. The segment operates at similar margins to FSG but with different cyclicality — defense spending provides some counter-cyclicality to commercial aviation.

Geographic Presence

• Primarily US-based operations: Most manufacturing facilities are in the United States
• Revenue mix: Approximately 70–75% US, 25–30% international
• International exposure: Through airline customers globally; some ETG defense customers overseas
• The company does not break out international revenue in the same granular way that pure-play international operators do

Scale

Business Model Strengths

1. Regulatory Moat: FAA PMA certification for each part is expensive and time-consuming. HEICO has a multi-decade head start in building its catalog. The catalog is the moat.
2. Value Proposition: Airlines and MROs face relentless cost pressure. HEICO parts at 30–40% discount to OEM are not optional cost savings — they are strategically necessary.
3. High Recurring Revenue: Aircraft maintenance is not discretionary. Aircraft must fly, and they must be maintained. Aftermarket parts are annuity-like revenue.
4. Disciplined M&A: HEICO has executed 100+ acquisitions over 30+ years without destroying value. The company acquires small, profitable niche businesses, retains founders/management, and integrates lightly. This is unusual for an acqui-growth model.
5. Asset-Light Manufacturing: HEICO parts businesses are not capital-intensive relative to OEM aerospace — no new aircraft program risk, no defense prime contractor risk.

What HEICO Is NOT

• Not an OEM (does not manufacture new aircraft)
• Not a defense prime contractor (ETG is a sub-tier supplier)
• Not exposed to aircraft production rates as a key variable (aftermarket depends on installed fleet utilization, not new production)
• Not a pure-play commercial aviation company (ETG provides meaningful diversification)

Key Competitive Relationships

• OEMs (Competitors/Partners): GE Aerospace, Pratt & Whitney (RTX), Safran, Honeywell — HEICO competes with their aftermarket parts businesses. Tension is ongoing: OEMs try to assert "back to OEM only" maintenance requirements; HEICO pushes FAA/DOT positions that PMA parts are legally interchangeable.
• TransDigm (TDG): Most similar public comp. Also in aerospace aftermarket, also highly acquisitive. Different model: TDG acquires businesses with sole-source positions and raises prices aggressively. HEICO competes on price (PMA discount vs. OEM). Different cultures.
• Airlines: Primary customers. Major US carriers (American, Delta, United, Southwest) are large HEICO customers. International carriers increasingly adopt PMA parts.
• MROs: Aviation service companies that maintain aircraft are major distribution channel partners and customers.

source: coverage-next-full ticker: HEI step: "12" title: Catalysts — Near-Term Drivers and Bull/Bear Framework created: 2026-05-29

HEI — Catalysts

Near-Term Catalysts (12–24 Month Horizon)

Catalyst 1: Wencor Integration Synergies Becoming Visible

Timeline: FY2025 (ongoing) Nature: Positive / earnings-accretive

The Wencor acquisition closed September 2023. Through FY2024, the focus was on integration and beginning to demonstrate revenue synergies. In FY2025 and beyond, management has signaled growing confidence in cross-selling opportunities:

• HEICO's PMA parts can be distributed through Wencor's distribution network to MRO customers
• Wencor's existing airline relationships provide new channels for HEICO PMA parts
• Cost synergies from overlapping back-office functions, procurement leverage, and logistics optimization

Market expectation: Analysts expect margin improvement in FSG from Wencor as synergies flow through. Any upside in FSG margins vs. the ~20–21% consensus would be a positive catalyst.

Catalyst 2: Continued Rapid Deleveraging

Timeline: FY2025–FY2026 Nature: Positive / re-rating catalyst

Post-Wencor Net Debt/EBITDA peaked at 3.6x in FY2023. At current FCF run rates ($700–800M/year), HEICO is targeting:

• Sub-3x by mid-FY2025
• Sub-2x by FY2026
• Historical leverage: <1x prior to Wencor

Reaching sub-2x leverage would:

1. Free capital for resumption of M&A pipeline at normal pace
2. Reduce interest expense burden (positive EPS impact)
3. Signal balance sheet health restored — historically correlated with multiple expansion for HEICO

Catalyst 3: Defense Electronics Demand Surge (ETG)

Timeline: FY2025–FY2026 Nature: Positive / revenue outperformance

NATO allies, post-Russia/Ukraine, are dramatically increasing defense budgets. European defense spending, in particular, is accelerating:

• HEICO's ETG serves US DoD + some NATO allies
• Increased procurement of electronic warfare systems, radar, and precision munitions benefits ETG's niche electronics
• US DoD is also expanding electronic warfare capabilities — several HEICO ETG subsidiaries have relevant positions
• Potential for organic ETG growth to exceed the ~15–18% analyst consensus

Risk: Specific program cancellations or delays could disappoint. Defense spending is a long-cycle business.

Catalyst 4: New PMA Catalog Expansion Accelerating

Timeline: Ongoing, 12–18 months Nature: Long-term positive / underappreciated by market

HEICO adds 200–400 new PMA approvals annually. Key developing areas:

• B787 and A350 composite structure parts — more complex but HEICO is investing
• CFM LEAP engine parts (for new A320neo/B737 MAX) — as LEAP engines age, HEICO's PMA catalog for this platform will be a growth driver through 2030+
• Regional jets (E-175, CRJ) — active PMA development program

Each new PMA approval has a high IRR (one-time certification cost, perpetual revenue stream). Analysts don't model catalog expansion ROI directly — any visible acceleration is a positive surprise.

Catalyst 5: M&A Pipeline Reopening Post-Deleveraging

Timeline: 12–24 months as leverage normalizes Nature: Positive / long-term EPS growth driver

With Wencor integration proceeding and leverage declining, HEICO's M&A engine is expected to re-engage at normal pace. Management has guided to returning to a cadence of 3–6 smaller deals per year:

• Target deal sizes: $20M–$300M
• Sectors: Niche aerospace aftermarket and defense electronics
• ROIC on historical acquisitions: 10–15% over 5 years

Every HEICO acquisition has historically been EPS-accretive within 12–24 months. Announcements of new deals tend to be received positively by the market.

Catalyst 6: Earnings Beats on Operational Leverage

Timeline: Every quarter Nature: Steady positive momentum

HEICO has beaten consensus EPS estimates in nearly every quarter for 10+ years. The pattern:

• Management gives conservative qualitative guidance
• Analysts set modest estimates
• Strong execution and operating leverage produces upside
• Stock typically reacts positively to earnings beats (5–10% moves common)

As Wencor integration matures and organic growth continues, the probability of consecutive beats through FY2025 is high.

Potential Negative Catalysts

Negative Catalyst 1: Air Travel Demand Shock

A significant exogenous event (pandemic, major geopolitical conflict, global recession) that materially reduces flight hours would pressure FSG revenue. Historical precedent (2020) shows HEICO's resilience is good but not infinite.

Negative Catalyst 2: OEM Competitive Response

If major OEMs (GE Aerospace, RTX) significantly accelerate LTSA penetration or use legal challenges to restrict PMA certification in major platforms, HEICO's addressable market could shrink. This is a slow-moving risk but a real one.

Negative Catalyst 3: Wencor Integration Disappoints

If synergies fail to materialize, FSG margins remain in the 19–20% range rather than improving to 22–24%, the investment case for Wencor's strategic merit weakens. This would be a negative signal for capital allocation discipline.

Negative Catalyst 4: Succession Announcement / Management Change

Any unexpected departure of key Mendelson family members or signals of succession disruption could trigger a valuation de-rating given the management premium embedded in the stock.

Bull Case

• Wencor synergies exceed expectations, FSG margins reach 23%+ by FY2026, driving EPS to $6.00+ vs. consensus $5.00–5.20, and the stock re-rates as the highest-quality compounder in industrials
• Defense electronics boom drives ETG to 20%+ organic growth through FY2026–FY2027, significantly above consensus, with new NATO procurement programs locking in multi-year sole-source positions
• Rapid deleveraging (sub-2x by FY2026) unlocks M&A engine at scale, enabling 5–6 acquisitions per year at accretive multiples, sustaining 15%+ EPS CAGR through the decade

Bear Case

• Air travel demand softens materially in 2025–2026 (recession + geopolitical), FSG revenue growth slows to <5%, Wencor's distribution margins compress, and HEICO's 40x+ multiple corrects significantly as growth expectations reset
• OEM LTSA penetration accelerates faster than expected, with major US carriers shifting 30–40% of their fleet maintenance to OEM-exclusive contracts by 2027, structurally reducing PMA addressable market and permanently capping FSG growth
• Wencor integration creates unexpected execution challenges, combining with elevated interest expense (~$130M/year) and a potential large acquisition misstep, resulting in EPS growth disappointing at <10% CAGR vs. the 15–20% embedded in the premium valuation